Truluck Joseph 4
4 · ADIAL PHARMACEUTICALS, INC. · Filed Aug 2, 2018
Insider Transaction Report
Form 4
Truluck Joseph
Chief Financial Officer
Transactions
- Conversion
Common Stock
2018-07-31+5,927→ 80,555 total - Conversion
Convertible Note
2018-07-31−5,927→ 0 totalExercise: $0.44→ Common Stock (5,927 underlying) - Conversion
Warrant
2018-07-31+5,927→ 5,927 totalExercise: $6.25From: 2018-07-31Exp: 2023-07-31→ Common Stock (5,927 underlying)
Footnotes (1)
- [F1]The 5,927 shares of common stock and a warrant to purchase 5,927 shares of common stock were issued upon automatic conversion of a convertible note in the principal amount of $1,980 at a conversion price of $0.44 per share upon consummation of the initial public offering on July 31, 2018.